Procyon Corporation, a publicly traded holding company, is dedicated to providing innovative and effective skin and wound care solutions through its subsidiary, AMERX Health Care Corporation. With over two decades of expertise since its acquisition in 1996, AMERX offers advanced proprietary products that address a range of skin problems, including wounds, ulcers, burns, and dermatitis. AMERX stands out in the market with its three proprietary brands: AMERIGEL® Advanced Skin and Wound Care, HELIX3® Bioactive Collagen, and EXTREMIT-EASE®.

These products are developed and manufactured in accordance with the highest standards of quality, as defined by the United States Federal Food, Drug and Cosmetic Act (FFDC Act). AMERX’s commitment to excellence is further demonstrated by its registrations with the Food & Drug Administration (FDA) and its adherence to current good manufacturing practices (CGMP). In a rapidly growing global market, AMERIGEL's products perfectly align with the increasing demand for effective wound care solutions.

Supported by clinical research, case studies, and in-vitro laboratory studies, AMERIGEL products have earned the trust of healthcare providers specializing in lower extremity skin and wound conditions. Join Procyon Corporation in its mission to enhance the well-being and quality of life for individuals with skin problems by exploring their impressive portfolio of AMERX products today